Medinol Ltd - Product Pipeline Analysis, 2018 Update

  • ID: 4267300
  • Company Profile
  • 27 pages
  • GlobalData
  • Medinol Ltd
1 of 5
Medinol Ltd (Medinol) is a medical device company that researches, develops and manufactures cardiovascular intervention solutions. The company’s products include coronary stent system, bare metal stents, PTCA dilatation catheter, biliary metallic stent and self expanding peripheral stent. Its services comprise research, development, coating, quality control, regulatory affairs, clinical trials and studies, manufacturing, drug elution, traditional polymer coating services, marketing and sales. Medinol uses Flexx2 catheter technology, WiZeCell, eDES coating, and unique manufacturing technology to develop its products. Its stents are cut by water-jet laser from cobalt-chromium alloy panels. The company has operations in Tel Aviv and Jerusalem, Israel; and Parsippany, the US. Medinol is headquartered in Tel Aviv, Israel.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Medinol Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5
  • Medinol Ltd Company Overview
  • Medinol Ltd Company Snapshot
  • Medinol Ltd Pipeline Products and Ongoing Clinical Trials Overview
  • Medinol Ltd - Pipeline Analysis Overview
  • Medinol Ltd - Key Facts
  • Medinol Ltd - Major Products and Services
  • Medinol Ltd Pipeline Products by Development Stage
  • Medinol Ltd Ongoing Clinical Trials by Trial Status
  • Medinol Ltd Pipeline Products Overview
  • Elunir Elastomer Drug Eluting Stent
  • Elunir Elastomer Drug Eluting Stent Product Overview
  • Elunir Elastomer Drug Eluting Stent Clinical Trial
  • Elunir Elastomer Drug Eluting Stent - 38mm
  • Elunir Elastomer Drug Eluting Stent - 38mm Product Overview
  • Elunir Elastomer Drug Eluting Stent - 44mm
  • Elunir Elastomer Drug Eluting Stent - 44mm Product Overview
  • Medinol Ltd - Key Competitors
  • Medinol Ltd - Key Employees
  • Medinol Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Recent Developments
  • Medinol Ltd, Recent Developments
  • Mar 19, 2018: Detroit Medical Center First to Use New Stent for Blocked Blood Vessels
  • Feb 06, 2018: DMC Heart Hospital is First in Michigan to Use the Narrowest Stent Width Available in the United States to Treat Coronary Disease
  • Jan 11, 2018: Cordis and Medinol Announce First U.S. Commercial Implants of Innovative EluNIR Drug-Eluting Stent
  • Nov 30, 2017: Cordis and Medinol Announce FDA Approval of the Innovative EluNIR Drug-Eluting Stent System
  • Oct 30, 2017: Cordis Showcases EluNIR Drug-Eluting Stent at TCT 2017
  • Oct 30, 2017: Cordis Showcases Medinol’s NIRxcell, a cobalt-chromium Bare Metal Coronary Stent at TCT 2017
  • Oct 26, 2017: Medinol Receives CE Mark for the EluNIR Ridaforolimus-Eluting Coronary Stent System, and announces first commercial implantations
  • Feb 16, 2017: Medinol Announces Appointment Of Harvey J. Berger, M.D., As Executive Chairman Of Medinol US
  • Dec 21, 2016: Medinol announces excellent clinical results for EluNIR, a novel Drug Eluting Stent
  • Nov 07, 2016: Medinol receives approval from the Japanese PMDA to begin clinical study on novel DES
  • Appendix
  • Methodology
  • About
  • Contact
  • Disclaimer
List of Tables
  • Medinol Ltd Pipeline Products and Ongoing Clinical Trials Overview
  • Medinol Ltd Pipeline Products by Equipment Type
  • Medinol Ltd Pipeline Products by Indication
  • Medinol Ltd Ongoing Clinical Trials by Trial Status
  • Medinol Ltd, Key Facts
  • Medinol Ltd, Major Products and Services
  • Medinol Ltd Number of Pipeline Products by Development Stage
  • Medinol Ltd Pipeline Products Summary by Development Stage
  • Medinol Ltd Ongoing Clinical Trials by Trial Status
  • Medinol Ltd Ongoing Clinical Trials Summary
  • Elunir Elastomer Drug Eluting Stent - Product Status
  • Elunir Elastomer Drug Eluting Stent - Product Description
  • Elunir Elastomer Drug Eluting Stent - BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) EUropean Angiography Study
  • Elunir Elastomer Drug Eluting Stent - BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) In Coronary Stenosis - PK Study
  • Elunir Elastomer Drug Eluting Stent - BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) in Coronary Stenosis Trial
  • Elunir Elastomer Drug Eluting Stent - Multi-center Study for Evaluating the Safety and Efficacy of the MedJ-01 Ridaforolimus Eluting Coronary Stent System (MedJ-01) In Coronary Stenosis Trial
  • Elunir Elastomer Drug Eluting Stent - 38mm - Product Status
  • Elunir Elastomer Drug Eluting Stent - 38mm - Product Description
  • Elunir Elastomer Drug Eluting Stent - 44mm - Product Status
  • Elunir Elastomer Drug Eluting Stent - 44mm - Product Description
  • Medinol Ltd, Key Employees
  • Medinol Ltd, Other Locations
  • Glossary
List of Figures
  • Medinol Ltd Pipeline Products by Equipment Type
  • Medinol Ltd Pipeline Products by Development Stage
  • Medinol Ltd Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • EndoCross Ltd.
  • Edwards Lifesciences (Israel) Ltd
  • Nicast Ltd
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll